GT Biopharma
在场
GT Biopharma 是一家在股票代码 GTBP (US) 下上市的公司。
高管
查看带有其 6 名主要高管的组织结构图
GT Biopharma 搜索最多的简介
- Michael Breen, Executive Chairman and Interim Chief Executive Offi...
- Bruce Wendel, Vice Chairman & Independent Director
- Rajesh Shrotriya, Independent Director
创建提醒
跟踪 GT Biopharma 的高管变动
生物技术
GT Biopharma 拥有 2,330 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Nuvig Therapeutics 刚刚宣布为 161 筹款数百万美元。 (公布2024十二月5号).
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
GT Biopharma 的最新新闻稿
- Press Releases :: GT Biopharma, Inc. (GTBP)
- GT Biopharma Reports Third Quarter 2024 Financial Results :: GT Biopharma, Inc. (GTBP)
- GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference :: GT Biopharma, Inc. (GTBP)
- GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024 :: GT Biopharma, Inc. (GTBP)
- GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update :: GT Biopharma, Inc. (GTBP)
- GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia :: GT Biopharma, Inc. (GTBP)
- GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules :: GT Biopharma, Inc. (GTBP)
- GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update :: GT Biopharma, Inc. (GTBP)
- GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results :: GT Biopharma, Inc. (GTBP)
- GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split :: GT Biopharma, Inc. (GTBP)
- View more press releases Close
关于 GT Biopharma 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Michael Breen 
